ArticleChemical science2018

Triple action Pt(iv) derivatives of cisplatin: a new class of potent anticancer agents that overcome resistance.

Emanuele Petruzzella et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.